Life SciencesLiability
Get a quote

TL;DR

Chicago anchors a deep digital-health and health-technology cluster spanning health-IT, care-navigation, benefits and payer technology, and digital therapeutics, supported by health-tech incubators and one of the largest payer and provider markets in the country. Insuring a digital-health operator here is a software-liability exercise, not a products-liability one: cyber and technology errors and omissions are the primary vehicles because the software is the product, HIPAA business-associate obligations attach to every provider and payer relationship, and Illinois adds a distinctive exposure through the Biometric Information Privacy Act (BIPA). Any product that captures a face, voice, or fingerprint carries a private-right-of-action risk that a traditional products policy does not touch.

Chicago digital health

Digital health insurance for Chicago health-technology companies.

Chicago has built a strong digital-health and health-technology economy, spanning health-IT platforms, care-navigation and benefits technology, payer and provider software, and digital therapeutics. That base is supported by dedicated health-tech incubators and by proximity to one of the largest concentrations of payers, health systems, and self-insured employers in the country, which gives local operators a deep customer market and a correspondingly dense set of contractual and regulatory obligations. The result is a company population whose core exposure is software and data, not a physical product.

Insuring a digital-health operator is therefore structurally different from insuring a device or pharmaceutical company. The harms that matter here flow from software failure, algorithm error, data compromise, and privacy law, so the program is built around cyber and technology errors and omissions rather than a products policy. Layered on top of the federal HIPAA framework, Illinois law adds the Biometric Information Privacy Act, one of the strictest biometric-privacy statutes in the country, which makes any biometric-capturing feature a first-order underwriting question in this market.

Get a quoteRun the Free Analyzer

Last updated 2026-07-14

Cluster shape

The Chicago digital-health cluster

The Chicago digital-health base is broad rather than narrow, covering health-IT and clinical-workflow software, care-navigation and patient-engagement platforms, benefits and payer technology, revenue-cycle and administrative tools, and digital therapeutics. Health-tech incubators in the metro have seeded a steady pipeline of early and growth-stage companies, and the region's large payer and provider presence gives them enterprise customers close at hand. This is a distinct population from Chicago's medical device and pharma clusters, which carry their own coverage architecture on separate pages.

Because most of these companies sell into health plans, health systems, and self-insured employers, the commercial reality is contractual and data-driven. Enterprise customers push privacy, security, and indemnity obligations down to the vendor through business-associate agreements and master services agreements, and they increasingly condition contracts on evidence of security controls and specific insurance limits. Underwriting a Chicago digital-health account starts with the data the company touches and the contracts it has signed, not with revenue alone.

The cluster spans a wide risk range. Pure software-as-a-service tools sit alongside clinical decision-support products, remote-monitoring and connected-app platforms, and products that capture biometric identifiers such as facial, voice, or fingerprint data. Each of those profiles drives a different combination of technology E&O, cyber, regulated-device, and biometric-privacy exposure, which is why a single generic technology policy rarely fits a health-technology company operating in Illinois.

Coverage architecture

How a Chicago digital-health program is built

For a digital-health company the software is the product, so cyber and technology errors and omissions are the primary product-liability vehicles rather than a traditional products policy. Technology E&O responds to economic loss from software failure, service outages, integration errors, and professional-services claims, while cyber responds to data breach, network security failure, privacy liability, regulatory defense, and the first-party costs of incident response, notification, and business interruption. These two lines are frequently written together for health-technology risks, and they carry the exposures a products form was never designed to address. Market-typical combined limits for early and growth-stage operators commonly run in the $1M to $10M range and scale with enterprise-contract requirements and data volume.

HIPAA business-associate scope attaches to almost every provider and payer relationship. When a digital-health company creates, receives, maintains, or transmits protected health information on behalf of a covered entity, it is a business associate and signs a business-associate agreement that imposes safeguard, breach-notification, and indemnity obligations directly on the vendor. The cyber and technology E&O program has to be structured to answer those contractual obligations, including regulatory defense and the notification costs a HIPAA breach triggers, because the business-associate agreement transfers real liability onto the company.

Two further structures matter for this cluster. Where a product functions as software as a medical device (SaMD) and is regulated by FDA as a device, the program has to contemplate regulated-device exposure and any resulting bodily-injury pathway alongside the technology and cyber lines. And where a product delivers algorithm-driven or AI decision-support, the risk that a recommendation contributes to a clinical or financial harm sits in technology E&O and, potentially, a bodily-injury trigger, so the responding policy has to be identified deliberately. Underwriters increasingly expect a SOC 2 examination as evidence of security control maturity, and a clean SOC 2 posture materially shapes both terms and pricing.

Regulatory + market context

Illinois BIPA and the biometric exposure

The defining regulatory feature of the Illinois market is the Biometric Information Privacy Act (BIPA), one of the strictest biometric-privacy laws in the country and, critically, one that carries a private right of action. Any digital-health product that captures biometric identifiers such as facial geometry, voice, or fingerprint data falls within its scope, and BIPA imposes notice, consent, and data-handling requirements whose violation can be litigated directly by affected individuals rather than only by a regulator. That private right of action makes BIPA a distinct and material exposure that has to be addressed alongside HIPAA, not folded into it.

Underwriting a biometric-capturing product in Illinois therefore turns on how the company collects consent, stores and retains biometric data, and manages vendor and processor relationships that touch it. Cyber and privacy coverage terms, including how biometric and statutory-privacy claims are treated, have to be read against the actual data the product captures, because a policy that covers HIPAA-style breach liability may still limit or exclude the biometric-privacy class that BIPA creates. In this market that gap is a first-order question, not a footnote.

Frequently asked

Common questions from Chicago digital health operators

Why are cyber and technology E&O the primary coverages for a digital-health company?

For a digital-health company the software is the product, so the harms that matter flow from software failure, algorithm error, data compromise, and privacy law rather than from a physical defect. Technology errors and omissions responds to economic loss from software failure, outages, integration errors, and professional-services claims, while cyber responds to data breach, privacy liability, regulatory defense, and first-party incident-response and notification costs. A traditional products-liability policy is structurally inadequate on its own because it was not designed to answer software and data exposures, which is why cyber and tech E&O, usually written together, form the core of the program.

Why is Illinois BIPA a major exposure for products that capture biometric data?

The Illinois Biometric Information Privacy Act (BIPA) is one of the strictest biometric-privacy laws in the country and carries a private right of action, meaning affected individuals can sue directly rather than waiting on a regulator. Any digital-health product that captures biometric identifiers such as facial geometry, voice, or fingerprint data falls within its notice, consent, and data-handling requirements, and a violation can generate individual and class litigation. Because that private right of action creates a distinct claims class, BIPA has to be addressed alongside HIPAA, and the cyber and privacy program has to be reviewed to confirm biometric-privacy claims are actually covered rather than limited or excluded.

When does a digital-health company have HIPAA business-associate obligations?

A digital-health company is a business associate whenever it creates, receives, maintains, or transmits protected health information on behalf of a covered entity such as a health plan or provider. That status is nearly universal for companies selling into payers and health systems, and it is formalized in a business-associate agreement that imposes safeguard, breach-notification, and indemnity obligations directly on the vendor. Those contractual obligations transfer real liability onto the company, so the cyber and technology E&O program has to be structured to answer them, including regulatory defense and the notification costs a HIPAA breach triggers.

When is a digital-health product regulated as software as a medical device (SaMD)?

A product is software as a medical device (SaMD) when the software itself performs a medical function, such as diagnosis, treatment, or clinical decision-support, and is regulated by FDA as a device rather than as a general wellness or administrative tool. When a product crosses into SaMD, the program has to contemplate regulated-device exposure and any resulting bodily-injury pathway in addition to the technology E&O and cyber lines, because a software defect can then contribute to patient harm. Products that deliver algorithm-driven or AI decision-support sit closest to this line, so identifying whether a product is regulated as a device, and which policy would respond, is a deliberate design step rather than an assumption.

Telehealth & digital health practice →Digital health startup insurance →Chicago medical device →Illinois state guide →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for Chicago digital health operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.